Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine最新文献

筛选
英文 中文
Do we need point-of-care testing to detect sickle cell trait before whole blood donation? 在全血捐献前,我们是否需要即时检测镰状细胞特征?
Satya Prakash, Namrata Datta, Debasish Mishra, Ansuman Sahu, Somnath Mukherjee
{"title":"Do we need point-of-care testing to detect sickle cell trait before whole blood donation?","authors":"Satya Prakash, Namrata Datta, Debasish Mishra, Ansuman Sahu, Somnath Mukherjee","doi":"10.1016/j.tracli.2025.09.265","DOIUrl":"https://doi.org/10.1016/j.tracli.2025.09.265","url":null,"abstract":"","PeriodicalId":94255,"journal":{"name":"Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145126173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Beyond fibrinogen counts: rethinking cryoprecipitate use in haemato-oncology. 超越纤维蛋白原计数:重新思考冷冻沉淀在血液肿瘤学中的应用。
RishiRaj Sinha
{"title":"Beyond fibrinogen counts: rethinking cryoprecipitate use in haemato-oncology.","authors":"RishiRaj Sinha","doi":"10.1016/j.tracli.2025.09.005","DOIUrl":"10.1016/j.tracli.2025.09.005","url":null,"abstract":"","PeriodicalId":94255,"journal":{"name":"Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145093331","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cryoprecipitate utilization review in light of recent guidelines: a single-center prospective analysis of haemato-oncology patients. 根据最新指南回顾低温沉淀的应用:一项针对血液肿瘤患者的单中心前瞻性分析。
Joyisa Deb, Daljit Kaur, Gita Negi, Zikra Syed, Aswin K Mohan, Priyanka Rathod, Ashish Jain, Uttam Kumar Nath
{"title":"Cryoprecipitate utilization review in light of recent guidelines: a single-center prospective analysis of haemato-oncology patients.","authors":"Joyisa Deb, Daljit Kaur, Gita Negi, Zikra Syed, Aswin K Mohan, Priyanka Rathod, Ashish Jain, Uttam Kumar Nath","doi":"10.1016/j.tracli.2025.09.004","DOIUrl":"10.1016/j.tracli.2025.09.004","url":null,"abstract":"<p><strong>Background: </strong>Cryoprecipitate, a cost-effective fibrinogen replacement, remains vital in managing coagulopathies, particularly in resource-limited settings. There is a wide variation of cryoprecipitate transfusion practices worldwide, even though it is widely transfused in various clinical settings.</p><p><strong>Study design and methods: </strong>This prospective observational study investigated cryoprecipitate utilization patterns in a tertiary care center in Northern India, focusing on Haemato-Oncology patients. This study was conducted over a period of one year, analyzing 350 transfusion events across 286 patients. Data on patient demographics, clinical and laboratory parameters, and transfusion indications were collected and evaluated for adherence to established guidelines.</p><p><strong>Results: </strong>Cryoprecipitate accounted for 2.1 % of blood component requests, predominantly from the Haemato-Oncology department (73 %). Among the transfusion events, 65.7 % were deemed appropriate based on guidelines, with the majority (85.6 %) occurring in Haemato-Oncology patients. Pre- and post-transfusion fibrinogen levels were documented in 45.4 % of events, revealing a mean fibrinogen increase of 0.71 g/L per dose. However, 34.3 % of events were inappropriate, largely due to transfusions without pre-transfusion fibrinogen measurements.</p><p><strong>Discussion: </strong>Key findings include hypofibrinogenemia as the leading indication for cryoprecipitate transfusion (74.3%) and significant differences in transfusion practices between Haemato-Oncology and non-Haemato-Oncology population cohorts. The study highlights the need for periodic utilization audits and continuous training of stakeholders to ensure adherence to evidence-based guidelines and reduce empirical transfusion practices. Future multi-center studies are recommended to establish standardized cryoprecipitate administration protocols and assess clinical outcomes.</p>","PeriodicalId":94255,"journal":{"name":"Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145035036","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Voluntary plasma donation 2.0: building trust, technology, and tomorrow's donor. 自愿献血2.0:建立信任、技术和未来的献血者。
RishiRaj Sinha
{"title":"Voluntary plasma donation 2.0: building trust, technology, and tomorrow's donor.","authors":"RishiRaj Sinha","doi":"10.1016/j.tracli.2025.09.003","DOIUrl":"10.1016/j.tracli.2025.09.003","url":null,"abstract":"","PeriodicalId":94255,"journal":{"name":"Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145007022","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
When blood types collide: misinformation, ethics, and the transfusion dilemma. 当血型碰撞:错误信息、伦理和输血困境。
RishiRaj Sinha, Rajkumar Kundavaram
{"title":"When blood types collide: misinformation, ethics, and the transfusion dilemma.","authors":"RishiRaj Sinha, Rajkumar Kundavaram","doi":"10.1016/j.tracli.2025.09.002","DOIUrl":"10.1016/j.tracli.2025.09.002","url":null,"abstract":"","PeriodicalId":94255,"journal":{"name":"Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145002338","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Closing the gap: blending CBME, simulation, and digital reinforcement in transfusion medicine education. 缩小差距:在输血医学教育中融合CBME、模拟和数字强化。
RishiRaj Sinha, Aakriti Puri
{"title":"Closing the gap: blending CBME, simulation, and digital reinforcement in transfusion medicine education.","authors":"RishiRaj Sinha, Aakriti Puri","doi":"10.1016/j.tracli.2025.08.007","DOIUrl":"10.1016/j.tracli.2025.08.007","url":null,"abstract":"","PeriodicalId":94255,"journal":{"name":"Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145002374","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Beyond haemoglobin: peronsalised iron strategies for safer donor return. 超越血红蛋白:个体化铁策略更安全的献血者返回。
RishiRaj Sinha, Devanshi Khare
{"title":"Beyond haemoglobin: peronsalised iron strategies for safer donor return.","authors":"RishiRaj Sinha, Devanshi Khare","doi":"10.1016/j.tracli.2025.09.001","DOIUrl":"10.1016/j.tracli.2025.09.001","url":null,"abstract":"","PeriodicalId":94255,"journal":{"name":"Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145002382","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
From chance to precision: formula-based transfusion as the future of red cell therapy. 从偶然到精确:基于配方的输血是红细胞治疗的未来。
RishiRaj Sinha
{"title":"From chance to precision: formula-based transfusion as the future of red cell therapy.","authors":"RishiRaj Sinha","doi":"10.1016/j.tracli.2025.08.004","DOIUrl":"10.1016/j.tracli.2025.08.004","url":null,"abstract":"","PeriodicalId":94255,"journal":{"name":"Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144994883","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clustering of adverse perinatal outcomes in women with multiple sensitising events: a data-driven approach using clinical and immunohematologic profiles. 具有多重致敏事件的妇女不良围产期结局聚类:使用临床和免疫血液学资料的数据驱动方法。
Anubhav Gupta, Meenakshi Gothwal, Garima Yadav, Swati Asati, Pratibha Singh
{"title":"Clustering of adverse perinatal outcomes in women with multiple sensitising events: a data-driven approach using clinical and immunohematologic profiles.","authors":"Anubhav Gupta, Meenakshi Gothwal, Garima Yadav, Swati Asati, Pratibha Singh","doi":"10.1016/j.tracli.2025.08.005","DOIUrl":"10.1016/j.tracli.2025.08.005","url":null,"abstract":"<p><strong>Background: </strong>Red-cell alloimmunisation is a preventable driver of haemolytic disease of the foetus and newborn, yet most risk scores rely on single-parameter thresholds and overlook clinically important heterogeneity.</p><p><strong>Objective: </strong>To uncover latent phenotypes among sensitised pregnancies by clustering routinely collected clinical and immunohaematologic variables.</p><p><strong>Methods: </strong>We retrospectively analysed 2084 antenatal records (2020-2021). Five variables-maternal antibody status, haemoglobin (Hb) concentration, cumulative number of sensitising events, gestational age at first positive antibody screen, and parity-were multiply imputed and scaled. A rule-based approximation of Gaussian mixture modelling and HDBSCAN assigned women to five clusters. Internal validity was assessed with the silhouette coefficient (0.41) and Davies-Bouldin index (0.88). Multivariable logistic regression evaluated the association between cluster membership and a composite adverse perinatal outcome, adjusting for maternal age and comorbidities.</p><p><strong>Results: </strong>Five clinically coherent clusters emerged (Cluster 1 = 13, Cluster 2 = 848, Cluster 3 = 26, Cluster 4 = 36, Cluster 5 = 513; 648 records lacked sufficient data for assignment). Cluster 1 combined antibody positivity with marked anaemia (mean Hb 8.6 ± 1.3 g/dL) and showed the highest risk of adverse outcome (adjusted OR 4.3, 95 % CI 2.7-6.8, p < 0.001). Cluster 3-seronegative women with preserved Hb (≥12 g/dL) but neonatal depression (1-min Apgar < 7 in 100 % of cases)-represented an unexpected high-risk phenotype. Cluster 5 (antibody-negative, Hb ≥ 12 g/dL, 1-min Apgar ≥ 7) served as the low-risk reference.</p><p><strong>Conclusion: </strong>Unsupervised clustering of simple antenatal parameters reveals hidden risk profiles that outperform single-threshold screening. This data-driven phenotyping could refine surveillance intensity and transfusion strategies in sensitised pregnancies.</p>","PeriodicalId":94255,"journal":{"name":"Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144994920","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Closing the iron gap: practical solutions to retain valued donors. 缩小“铁沟”:留住有价值捐助者的实际解决方案。
RishiRaj Sinha, Devanshi Khare
{"title":"Closing the iron gap: practical solutions to retain valued donors.","authors":"RishiRaj Sinha, Devanshi Khare","doi":"10.1016/j.tracli.2025.08.006","DOIUrl":"10.1016/j.tracli.2025.08.006","url":null,"abstract":"","PeriodicalId":94255,"journal":{"name":"Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144994881","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信